Events and news
SARS-CoV-2
VIDIA spol s r.o. introduces new products SARS-CoV-2 for accurate antibodies and antigens detection.
View a portfolio of diagnostic tests designed to detect SARS-CoV-2
Rapid-VIDITEST
VIDIA spol s r.o. brings a Rapid-VIDITEST for qualitative detection of SARS-CoV-2 antigens and for simultaneous detection of SARS-CoV-2 antigens and Influenza A and Influenza B virus antigens in human nasopharyngeal swab specimens.
View a portfolio of diagnostic tests designed to detect SARS-CoV-2
Rapid-VIDITEST
VIDIA spol s r.o. offers a Rapid-VIDITEST for quantitative detection of IgG and IgM antibodies to SARS-CoV-2 in human whole whole blood, serum or plasma specimens.
View a portfolio of diagnostic tests designed to detect SARS-CoV-2
ELISA-VIDITEST
VIDIA spol s r.o. offers a new generation of IVD serological kits ELISA-VIDITEST and MONO-VIDITEST for detection of antibodies against nucleocapsid proteine (NP) and separately protein Spike (S1) of the SARS-CoV-2.
View a portfolio of diagnostic tests designed to detect SARS-CoV-2
